161 related articles for article (PubMed ID: 24300468)
1. American Society of Clinical Oncology 2013: summary of scientific advancements in gynecologic cancer.
Eskander RN; Tewari KS
Int J Gynecol Cancer; 2014 Jan; 24(1):13-8. PubMed ID: 24300468
[TBL] [Abstract][Full Text] [Related]
2. American Society of Clinical Oncology 2012 Annual Meeting: highlights from the gynecologic oncology track.
Tewari KS
Int J Gynecol Cancer; 2012 Nov; 22(9):1634-9. PubMed ID: 23095779
[TBL] [Abstract][Full Text] [Related]
3. Epidemiological guideline influence on the therapeutic trend and patient outcome of uterine cervical cancer in Japan: Japan society of gynecologic oncology guideline evaluation committee project.
Shigeta S; Shida M; Nagase S; Ikeda M; Takahashi F; Shibata T; Yamagami W; Katabuchi H; Yaegashi N; Aoki D; Mikami M
Gynecol Oncol; 2020 Oct; 159(1):248-255. PubMed ID: 32718728
[TBL] [Abstract][Full Text] [Related]
4. [VEGF--targeted therapy for the treatment of cervical cancer --literature review].
Salomon-Perzyńska M; Perzyński A; Rembielak-Stawecka B; Michalski B; Skrzypulec-Plinta V
Ginekol Pol; 2014 Jun; 85(6):461-5. PubMed ID: 25029813
[TBL] [Abstract][Full Text] [Related]
5. [State of art and future prospects in cervical cancer].
Horn LC
Zentralbl Gynakol; 2001 Apr; 123(4):171-2. PubMed ID: 11370521
[No Abstract] [Full Text] [Related]
6. Perspectives in gynecologic oncology -- Third European Conference.
Horiot JC
IDrugs; 2006 Mar; 9(3):154-6. PubMed ID: 16523373
[No Abstract] [Full Text] [Related]
7. Updates from the 2013 Society for Neuro-Oncology annual and World Federation for Neuro-Oncology quadrennial meeting.
Lukas RV; Amidei C
Tumori; 2014; 100(3):358-62. PubMed ID: 25076251
[TBL] [Abstract][Full Text] [Related]
8. Report From the 20th Meeting of the European Society of Gynaecological Oncology (ESGO 2017).
Zalewski K; Piovano E; Razumova Z; Selcuk I; Nikolova T
Int J Gynecol Cancer; 2018 Jun; 28(5):1050-1053. PubMed ID: 29757877
[TBL] [Abstract][Full Text] [Related]
9. A Markov model to evaluate cost-effectiveness of antiangiogenesis therapy using bevacizumab in advanced cervical cancer.
Minion LE; Bai J; Monk BJ; Robin Keller L; Ramez EN; Forde GK; Chan JK; Tewari KS
Gynecol Oncol; 2015 Jun; 137(3):490-6. PubMed ID: 25766118
[TBL] [Abstract][Full Text] [Related]
10. Avastin for breast cancer, 2005-2011: requiescat in pacem?
Burstein HJ
J Natl Compr Canc Netw; 2011 Dec; 9(12):1321-3. PubMed ID: 22157551
[No Abstract] [Full Text] [Related]
11. [Mammary cancerology and gynecology. 35th Congress of the American Society of Clinical Oncology (ASCO) Atlanta (United States), May 1999].
Mabro M
Rev Med Interne; 1999 Oct; 20(10):855-7. PubMed ID: 10573720
[No Abstract] [Full Text] [Related]
12. American Society of Clinical Oncology (ASCO) - 55th Annual Meeting (May 31-June 4, 2019 - Chicago, Illinois, USA).
Kibble A; Kuenneman K; de Las Heras Prat P
Drugs Today (Barc); 2019 Jun; 55(6):407-415. PubMed ID: 31250844
[TBL] [Abstract][Full Text] [Related]
13. Improved survival with bevacizumab in advanced cervical cancer.
Tewari KS; Sill MW; Long HJ; Penson RT; Huang H; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Michael HE; Monk BJ
N Engl J Med; 2014 Feb; 370(8):734-43. PubMed ID: 24552320
[TBL] [Abstract][Full Text] [Related]
14. International Gynecologic Cancer Society (IGCS) 2016: Meeting report.
Del Carmen MG; Rice LW
Gynecol Oncol; 2017 Jan; 144(1):11-15. PubMed ID: 27847107
[No Abstract] [Full Text] [Related]
15. RTOG 0417: efficacy of bevacizumab in combination with definitive radiation therapy and cisplatin chemotherapy in untreated patients with locally advanced cervical carcinoma.
Schefter T; Winter K; Kwon JS; Stuhr K; Balaraj K; Yaremko BP; Small W; Sause W; Gaffney D;
Int J Radiat Oncol Biol Phys; 2014 Jan; 88(1):101-5. PubMed ID: 24331655
[TBL] [Abstract][Full Text] [Related]
16. Bevacizumab for advanced cervical cancer: patient-reported outcomes of a randomised, phase 3 trial (NRG Oncology-Gynecologic Oncology Group protocol 240).
Penson RT; Huang HQ; Wenzel LB; Monk BJ; Stockman S; Long HJ; Ramondetta LM; Landrum LM; Oaknin A; Reid TJ; Leitao MM; Method M; Michael H; Tewari KS
Lancet Oncol; 2015 Mar; 16(3):301-11. PubMed ID: 25638326
[TBL] [Abstract][Full Text] [Related]
17. Major clinical research advances in gynecologic cancer in 2017.
Suh DH; Kim M; Lee KH; Eom KY; Kjeldsen MK; Mirza MR; Kim JW
J Gynecol Oncol; 2018 Mar; 29(2):e31. PubMed ID: 29468855
[TBL] [Abstract][Full Text] [Related]
18. Highlights from the 52nd Annual Meeting of the American Society of Clinical Oncology (ASCO) (June 3-7, 2016 - Chicago, Illinois, USA).
Kibble A; Al-Shamahi A; Kuennemann K; Marqués F; Tremosa L; Cole P
Drugs Today (Barc); 2016 Jul; 52(7):407-23. PubMed ID: 27540600
[TBL] [Abstract][Full Text] [Related]
19. Development of a platform for systemic antiangiogenesis therapy for advanced cervical cancer.
Tewari KS; Monk BJ
Clin Adv Hematol Oncol; 2014 Nov; 12(11):737-48. PubMed ID: 25674713
[TBL] [Abstract][Full Text] [Related]
20. [New data concerning breast carcinoma. A report on the 34th Meeting of the American Society of Clinical Oncology, Los Angeles, Calif., USA, May 16-19, 1998].
Gerber B; Krause A
Gynakol Geburtshilfliche Rundsch; 1999; 39(3):136-9. PubMed ID: 10420058
[No Abstract] [Full Text] [Related]
[Next] [New Search]
